BusinessNovan to Present Positive Phase 2 Results for SB208 Antifungal Program at Winter Clinical Dermatology ConferenceBy Nasdaq OMXJan 11, 2018, 2:10 PM UTC
BusinessNovan Reports Positive Topline Results with SB208 in Phase 2 TrialBy Nasdaq OMXApr 12, 2017, 10:07 AM UTC
